Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum
2 other identifiers
interventional
12
1 country
1
Brief Summary
Unhealthy alcohol use among women with and at risk for HIV can interrupt critical steps in the HIV prevention and care continuum, is associated with HIV transmission risk behaviors, and contributes to health disparities. Thus it is critical to accurately identify alcohol use and implement alcohol interventions among women with and at risk for HIV to optimize health outcomes. The proposed pilot study will examine the implementation and effects of a computer delivered brief alcohol intervention with peer navigation/Community Health Worker compared to usual care on alcohol use, linkage to health services, and uptake of HIV prevention practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started Sep 2021
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2019
CompletedFirst Posted
Study publicly available on registry
September 16, 2019
CompletedStudy Start
First participant enrolled
September 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
ExpectedDecember 1, 2025
November 1, 2025
2.4 years
September 12, 2019
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Intervention Feasibility as assessed by a 4-item scale
Feasibility of the Intervention will be assessed by the Mean/Median score on a 4 item scale that measures the extent to which the new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Score ranges from 5-20 on the 4 item scale. Higher score means greater feasibility.
3 months
Intervention Acceptability as assessed by a 4-item scale
Acceptability of the Intervention will be assessed by the Mean/Median score on a 4 item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Score ranges from 5-20 on the 4 item scale. Higher score means greater acceptability.
3 months
Secondary Outcomes (4)
Number of participants linked to services
3 months
Number of participants with pre-exposure prophylaxis (PrEP) or condom uptake
3 months
Number of drinking days
At 3 months
Number of heavy drinking days
At 3 months
Other Outcomes (1)
Number of condom-less sex episodes
3 months
Study Arms (1)
Computer-delivered brief alcohol intervention (CBI-CC)
EXPERIMENTALParticipants will be offered only the Computer-delivered brief alcohol intervention with peer navigation from beginning of study to the end.
Interventions
Computer delivered brief alcohol intervention enhanced with information of HIV infection, HIV risk, and comorbid mental health disorders
Eligibility Criteria
You may qualify if:
- At risk and Women with HIV ≥18 years
- Alcohol misuse, defined as \>7 standard drinks per week or \> 3 drinks per occasion in the last three months or AUDIT-C ≥3
- Able to understand English
- Able to read at a 5th grade level.
- sex under the influence of alcohol or
- exchanging sex for money or other resources or
- unprotected vaginal or anal sex or illicit drug use in the last 12 months
You may not qualify if:
- Pregnant (will be referred immediately to alcohol, mental health, substance use treatment as needed)
- Non-English speaking
- Unable to receive text messages
- Actively psychotic, or otherwise not able to participate in the computer delivered brief intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins University
Baltimore, Maryland, 21287, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Geetanjali Chander
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2019
First Posted
September 16, 2019
Study Start
September 14, 2021
Primary Completion
January 25, 2024
Study Completion (Estimated)
November 1, 2026
Last Updated
December 1, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share